Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa. Treatment with intravenous immune globulin.
暂无分享,去创建一个
[1] M. Pollack,et al. Antibody activity against Pseudomonas aeruginosa in immune globulins prepared for intravenous use in humans. , 1983, The Journal of infectious diseases.
[2] J. Janda,et al. Pseudomonas aeruginosa enzyme profiling: predictor of potential invasiveness and use as an epidemiological tool , 1981, Journal of clinical microbiology.
[3] J. Lundblad,et al. A New Preparation of Modified Immune Serum Globulin (Human) Suitable for Intravenous Administration , 1981, Vox sanguinis.
[4] J. Lundblad,et al. A New Preparation of Modified Immune Serum Globulin (Human) Suitable for Intravenous Administration , 1981, Vox sanguinis.
[5] P. B. Fernandes,et al. Demonstration of cell envelope-bound exotoxin A in Pseudomonas aeruginosa , 1980, Infection and immunity.
[6] C. Haidaris,et al. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: extracellular protease and elastase as in vivo virulence factors. , 1979, Canadian journal of microbiology.
[7] B. Wretlind,et al. Assessment of protease (elastase) as a Pseudomonas aeruginosa virulence factor in experimental mouse burn infection , 1979, Infection and immunity.
[8] I. A. Holder,et al. Role of Exotoxin and Protease as Possible Virulence Factors in Experimental Infections with Pseudomonas aeruginosa , 1978, Infection and immunity.
[9] S. Davis,et al. Efficacy of modified human immune serum globulin in the treatment of experimental murine infections with seven immunotypes of Pseudomonas aeruginosa. , 1975, The Journal of infectious diseases.
[10] I. A. Holder,et al. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model. , 1975, The Journal of infectious diseases.
[11] K. Morihara,et al. Effects of protease and elastase from Pseudomonas aeruginosa on skin. , 1975, The Japanese journal of experimental medicine.
[12] J. Wesley,et al. Immunization against Pseudomonas in infection after thermal injury. , 1974, The Journal of infectious diseases.
[13] K. Miller,et al. Elastase of Pseudomonas aeruginosa: Inactivation of Complement Components and Complement-Derived Chemotactic and Phagocytic Factors , 1974, Infection and immunity.
[14] P. Liu,et al. Exotoxins of Pseudomonas aeruginosa. I. Factors that influence the production of exotoxin A. , 1973, The Journal of infectious diseases.
[15] H. C. Hopps,et al. Staining of bacteria in tissue sections: a reliable gram stain method. , 1973, American journal of clinical pathology.
[16] I. A. Holder,et al. Burn wounds: microbiology, local host defenses, and current therapy. , 1973, CRC critical reviews in clinical laboratory sciences.
[17] S. Saslaw,et al. Effect of Vincristine Sulfate on Pseudomonas Infections in Monkeys , 1972, Infection and immunity.
[18] O. Pavlovskis,et al. Pseudomonas aeruginosa exotoxin: effect on cell cultures. , 1972, The Journal of infectious diseases.
[19] I. A. Holder,et al. Infected surface wound: an experimental model and a method for the quantitation of bacteria in infected tissues. , 1972, Applied microbiology.
[20] I. A. Holder,et al. Enhanced survival in burned mice treated with antiserum prepared against normal and burned skin. , 1971, The Journal of trauma.
[21] B. Macmillan. Ecology of bacteria colonizing the burned patient given topical and systemic gentamicin therapy: a five-year study. , 1971, The Journal of infectious diseases.
[22] F. Kobayashi. Experimental infection with Pseudomonas aeruginosa in mice. I. The virulence of Pseudomonas aeruginosa for mice. , 1971, Japanese journal of microbiology.
[23] F. Kobayashi. Experimental Infection with Pseudomonas aeruginosa in Mice , 1971 .
[24] J. Alexander,et al. Immunological Control of Pseudomonas Infection in Burn Patients: A Clinical Evaluation , 1971 .
[25] W. Altemeier,et al. Topical and systemic antibacterial agents in the treatment of burns. , 1970, Annals of surgery.
[26] C. Janeway,et al. Intravenous dissociated gamma globulin in control of hypogammaglobulinemia. , 1969, Vox sanguinis.
[27] I. Feller,et al. Pseudomonas vaccine and hyperimmune plasma for burned patients. , 1968, Archives of surgery.
[28] M. García,et al. The lethal events in experimental Pseudomonas aeruginosa infection of mice. , 1968, The Journal of infectious diseases.
[29] A. Mason,et al. Surface Infection with Pseudomonas Aeruginosa , 1964, Annals of surgery.
[30] Ronald J. McRipley,et al. Increased Susceptibility of Burned Rats to Pseudomonas aeruginosa∗ , 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[31] P. Stastny,et al. Role of infection in mortality from severe burns. Evaluation of plasma, gamma-globulin, albumin and saline-solution therapy in a group of Peruvian children. , 1962, The New England journal of medicine.
[32] H. Isliker,et al. Intravenous Administration of Human γ‐Globulin * , 1962 .
[33] B. Holloway. Genetic recombination in Pseudomonas aeruginosa. , 1955, Journal of general microbiology.
[34] L. Reed,et al. A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .